» Articles » PMID: 6459341

A Molecular Defect in Two Families with Hemolytic Poikilocytic Anemia: Reduction of High Affinity Membrane Binding Sites for Ankyrin

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1981 Dec 1
PMID 6459341
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Patients from two families with chronic hemolytic anemia have been studied. The erythrocytes are very fragile and appear microcytic with a great variety of shapes. Clinical evaluation failed to identify traditionally recognized causes of hemolysis. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) showed no significant abnormality of the major polypeptide bands. Erythrocytes spectrin-ankyrin and ankyrin-membrane interactions were analyzed with 125I-labeled spectrin, 125I-labeled ankyrin, and inside-out vesicles. Patients' vesicles bound 125I-spectrin normally. Likewise, patients' spectrin and ankyrin competed normally for the binding sites on control membranes. None of the individual components appeared to have abnormal thermal sensitivity. Ankyrin-stripped, inside-out vesicles prepared from the patients bound less 125I-ankyrin than did vesicles prepared from normals (P less than 0.05 for all corresponding points in the high-affinity region). Scatchard analysis showed the most significant abnormality to be a 50% reduction in the high affinity ankyrin binding sites. Similar experiments were performed with blood from patients with spherocytosis and splenectomized controls, but no abnormalities were detected. The water soluble 43,000-dalton fragments of band 3 (the high-affinity ankyrin binding sites) were prepared from one of the patients and competed normally for 125I-ankyrin binding in solution. This suggests that the primary structural defect is a reduction in the number of high affinity membrane binding sites for ankyrin, and is consistent with an abnormal organization of band 3 in the membrane.

Citing Articles

Rare Anemias: Are Their Names Just Smoke and Mirrors?.

Simionato G, van Wijk R, Quint S, Wagner C, Bianchi P, Kaestner L Front Physiol. 2021; 12:690604.

PMID: 34177628 PMC: 8222994. DOI: 10.3389/fphys.2021.690604.


Biomechanical properties of red blood cells in health and disease towards microfluidics.

Tomaiuolo G Biomicrofluidics. 2014; 8(5):051501.

PMID: 25332724 PMC: 4189537. DOI: 10.1063/1.4895755.


Ankyrin-G coordinates intercalated disc signaling platform to regulate cardiac excitability in vivo.

Makara M, Curran J, Little S, Musa H, Polina I, Smith S Circ Res. 2014; 115(11):929-38.

PMID: 25239140 PMC: 4224970. DOI: 10.1161/CIRCRESAHA.115.305154.


Control of erythrocyte membrane-skeletal cohesion by the spectrin-membrane linkage.

Blanc L, Salomao M, Guo X, An X, Gratzer W, Mohandas N Biochemistry. 2010; 49(21):4516-23.

PMID: 20433199 PMC: 3056085. DOI: 10.1021/bi1003684.


Cardiac cytoskeleton and arrhythmia: an unexpected role for protein 4.1R in cardiac excitability.

Cunha S, Mohler P Circ Res. 2008; 103(8):779-81.

PMID: 18845816 PMC: 2742414. DOI: 10.1161/CIRCRESAHA.108.186460.


References
1.
Ungewickell E, Gratzer W . Self-association of human spectrin. A thermodynamic and kinetic study. Eur J Biochem. 1978; 88(2):379-85. DOI: 10.1111/j.1432-1033.1978.tb12459.x. View

2.
Greenquist A, SHOHET S, Bernstein S . Marked reduction of spectrinin hereditary spherocytosis in the common house mouse. Blood. 1978; 51(6):1149-55. View

3.
Kahn C, Goldfine I, Neville Jr D, De Meyts P . Alterations in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone. Endocrinology. 1978; 103(4):1054-66. DOI: 10.1210/endo-103-4-1054. View

4.
Marchesi V . Functional proteins of the human red blood cell membrane. Semin Hematol. 1979; 16(1):3-20. View

5.
Luna E, Kidd G, Branton D . Identification by peptide analysis of the spectrin-binding protein in human erythrocytes. J Biol Chem. 1979; 254(7):2526-32. View